Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19833700 | 1.00 | CHRM1 (0.43) | CHRM1GBA1LPAR1LPAR2LPAR3 | |
| SCHEMBL19835246 | 1.00 | CHRM1 (0.43) | CHRM1GBA1LPAR1LPAR2LPAR3 | |
| SCHEMBL19835262 | 1.00 | CHRM1 (0.43) | CHRM1GBA1LPAR1LPAR2LPAR3 | |
| SCHEMBL19834963 | 0.97 | CHRM1 (0.43) | CHRM1GBA1LPAR1LPAR2LPAR3 | |
| SCHEMBL12179814 | 0.96 | CHRM1 (0.43) | CHRM1 | |
| SCHEMBL19835251 | 0.96 | CHRM1 (0.43) | CHRM1 | |
| SCHEMBL19835253 | 0.96 | CHRM1 (0.43) | CHRM1 | |
| SCHEMBL19833602 | 0.91 | GBA1 (0.46) | CHRM1GBA1 | |
| SCHEMBL19834937 | 0.91 | GBA1 (0.46) | CHRM1GBA1 | |
| SCHEMBL14924890 | 0.89 | CHRM1 (0.47) | CHRM1GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170349532-A1 | CATIONIC LIPID | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349532-A1 | CATIONIC LIPID | LPAR3, ACOX3, H1-3 | CHRM1 1475/4885GBA1 407/4885LPAR1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.